The supervisory board of Selvita has appointed Edyta Jaworska managing board member, responsible for the development of its integrated drug discovery services.
Jaworska joined Selvita in 2012, starting as a Business Development Manager responsible for the sales and development of Selvita in selected Western European countries.
In 2014, she was promoted to the position of Business Development Director, taking on management of a sales team responsible for the sales and development of Selvita services in Western Europe, Israel and Japan.
“As part of our continued corporate growth initiatives in the drug discovery services business segment we decided to strengthen our management board with Edyta, who has always excelled in her previous roles at Selvita and is responsible for the development of our integrated service activities,” said Pawel Przewiezlikowski, CEO at Selvita.
“The appointment to the Selvita management board is not only a great honour for me, but also gives me the opportunity to develop new successful collaborations with leading global biotech and pharmaceutical industry partners and to broaden the existing relationships,” commented Jaworska.
Jaworska is a graduate of the University of Economics in Krakow, where she graduated with an MSc in Economics and postgraduate diploma in Finance Management.
She also studied at the University of Southern Denmark in Odense. She holds an MBA degree from Stockholm University and Krakow University of Economics joint programme.
Before she joined Selvita, she has gained several years of experience in managerial positions in various healthcare companies including OneMed group and International Nephrology Centers.
